Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 178 entries
Sorted by: Best Match Show Resources per page
Caffeine Ingestion Improves Repeated Freestyle Sprints in Elite Male Swimmers.

Journal of sports science & medicine

Goods PS, Landers G, Fulton S.
PMID: 28344456
J Sports Sci Med. 2017 Mar 01;16(1):93-98. eCollection 2017 Mar.

The purpose of this investigation was to determine the efficacy of a moderate dose of caffeine to improve repeat-sprint performance in elite freestyle sprinters. Nine highly trained male swimmers performed 6 x 75 m freestyle sprints on two occasions...

Cite
Goods PS, Landers G, Fulton S. Caffeine Ingestion Improves Repeated Freestyle Sprints in Elite Male Swimmers. J Sports Sci Med. 2017;16(1):93-98
Goods, P. S., Landers, G., & Fulton, S. (2017). Caffeine Ingestion Improves Repeated Freestyle Sprints in Elite Male Swimmers. Journal of sports science & medicine, 16(1), 93-98.
Goods, Paul S R, et al. "Caffeine Ingestion Improves Repeated Freestyle Sprints in Elite Male Swimmers." Journal of sports science & medicine vol. 16,1 (2017): 93-98.
Goods PS, Landers G, Fulton S. Caffeine Ingestion Improves Repeated Freestyle Sprints in Elite Male Swimmers. J Sports Sci Med. 2017 Mar 01;16(1):93-98. eCollection 2017 Mar. PMID: 28344456; PMCID: PMC5358037.
Copy Download .nbib Format: NLM
It's happening sooner than you think: spotlighting the pre-medical realm.

Medical education

Michalec B, Cuddy MM, Hafferty P, Hanson MD, Kanter SL, Littleton D, Martimianakis MAT, Michaels R, Hafferty FW.
PMID: 29574960
Med Educ. 2018 Apr;52(4):359-361. doi: 10.1111/medu.13531.

No abstract available.

Cite
Michalec B, Cuddy MM, Hafferty P, et al. It's happening sooner than you think: spotlighting the pre-medical realm. Med Educ. 2018;52(4):359-361doi: 10.1111/medu.13531.
Michalec, B., Cuddy, M. M., Hafferty, P., Hanson, M. D., Kanter, S. L., Littleton, D., Martimianakis, M. A. T., Michaels, R., & Hafferty, F. W. (2018). It's happening sooner than you think: spotlighting the pre-medical realm. Medical education, 52(4), 359-361. https://doi.org/10.1111/medu.13531
Michalec, Barret, et al. "It's happening sooner than you think: spotlighting the pre-medical realm." Medical education vol. 52,4 (2018): 359-361. doi: https://doi.org/10.1111/medu.13531
Michalec B, Cuddy MM, Hafferty P, Hanson MD, Kanter SL, Littleton D, Martimianakis MAT, Michaels R, Hafferty FW. It's happening sooner than you think: spotlighting the pre-medical realm. Med Educ. 2018 Apr;52(4):359-361. doi: 10.1111/medu.13531. PMID: 29574960.
Copy Download .nbib Format: NLM
Budget Impact of Orphan Drugs In the Netherlands In The Period 2006-2012.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Kanters TA, Steenhoek A, Hakkaart L.
PMID: 27201654
Value Health. 2014 Nov;17(7):A525. doi: 10.1016/j.jval.2014.08.1654. Epub 2014 Oct 26.

No abstract available.

Cite
Kanters TA, Steenhoek A, Hakkaart L. Budget Impact of Orphan Drugs In the Netherlands In The Period 2006-2012. Value Health. 2014;17(7):A525doi: 10.1016/j.jval.2014.08.1654.
Kanters, T. A., Steenhoek, A., & Hakkaart, L. (2014). Budget Impact of Orphan Drugs In the Netherlands In The Period 2006-2012. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A525. https://doi.org/10.1016/j.jval.2014.08.1654
Kanters, T A, et al. "Budget Impact of Orphan Drugs In the Netherlands In The Period 2006-2012." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A525. doi: https://doi.org/10.1016/j.jval.2014.08.1654
Kanters TA, Steenhoek A, Hakkaart L. Budget Impact of Orphan Drugs In the Netherlands In The Period 2006-2012. Value Health. 2014 Nov;17(7):A525. doi: 10.1016/j.jval.2014.08.1654. Epub 2014 Oct 26. PMID: 27201654.
Copy Download .nbib Format: NLM
Understanding the Journal's Impact.

Academic medicine : journal of the Association of American Medical Colleges

Kanter SL.
PMID: 19707044
Acad Med. 2009 Sep;84(9):1169-70. doi: 10.1097/ACM.0b013e3181b7ffa6.

No abstract available.

Cite
Kanter SL. Understanding the Journal's Impact. Acad Med. 2009;84(9):1169-70doi: 10.1097/ACM.0b013e3181b7ffa6.
Kanter, S. L. (2009). Understanding the Journal's Impact. Academic medicine : journal of the Association of American Medical Colleges, 84(9), 1169-70. https://doi.org/10.1097/ACM.0b013e3181b7ffa6
Kanter, Steven L. "Understanding the Journal's Impact." Academic medicine : journal of the Association of American Medical Colleges vol. 84,9 (2009): 1169-70. doi: https://doi.org/10.1097/ACM.0b013e3181b7ffa6
Kanter SL. Understanding the Journal's Impact. Acad Med. 2009 Sep;84(9):1169-70. doi: 10.1097/ACM.0b013e3181b7ffa6. PMID: 19707044.
Copy Download .nbib Format: NLM
Perspective: "How to fix the premedical curriculum" revisited.

Academic medicine : journal of the Association of American Medical Colleges

Gunderman RB, Kanter SL.
PMID: 19202486
Acad Med. 2008 Dec;83(12):1158-61. doi: 10.1097/ACM.0b013e31818c6515.

The authors celebrate the 30th anniversary of Lewis Thomas's provocative essay, "How to Fix the Premedical Curriculum," by reexamining its three central themes: the influence of medical schools on undergraduate education, the selection of students for admission to medical...

Cite
Gunderman RB, Kanter SL. Perspective: "How to fix the premedical curriculum" revisited. Acad Med. 2008;83(12):1158-61doi: 10.1097/ACM.0b013e31818c6515.
Gunderman, R. B., & Kanter, S. L. (2008). Perspective: "How to fix the premedical curriculum" revisited. Academic medicine : journal of the Association of American Medical Colleges, 83(12), 1158-61. https://doi.org/10.1097/ACM.0b013e31818c6515
Gunderman, Richard B, and Kanter, Steven L. "Perspective: "How to fix the premedical curriculum" revisited." Academic medicine : journal of the Association of American Medical Colleges vol. 83,12 (2008): 1158-61. doi: https://doi.org/10.1097/ACM.0b013e31818c6515
Gunderman RB, Kanter SL. Perspective: "How to fix the premedical curriculum" revisited. Acad Med. 2008 Dec;83(12):1158-61. doi: 10.1097/ACM.0b013e31818c6515. PMID: 19202486.
Copy Download .nbib Format: NLM
The application of (Z)-3-aryl-3-haloenoic acids to the synthesis of (Z)-5-benzylidene-4-arylpyrrol-2(5H)-ones.

Tetrahedron

Gupton JT, Telang N, Banner EJ, Kluball EJ, Hall KE, Finzel KL, Jia X, Bates SR, Welden RS, Giglio BC, Eaton JE, Barelli PJ, Firich LT, Stafford JA, Coppock MB, Worrall EF, Kanters RP, Keertikar K, Osterman R.
PMID: 21135918
Tetrahedron. 2010 Nov 20;66(47):9113-9122. doi: 10.1016/j.tet.2010.09.080.

Studies directed at the synthesis of (Z)-5-benzylidene-4-arylpyrrol-2(5H)-ones from (Z)-3-aryl-3-haloenoic acids are described. The successful strategy relies on the preparation of (Z)-3-aryl-3-haloenoic acids from acetophenones through the corresponding (Z)-3-aryl-3-haloenals and the conversion of the (Z)-3-aryl-3-haloenoic acids to (Z)-5-benzylidene-4-aryl-5H-furan-2-ones. The furanones...

Cite
Gupton JT, Telang N, Banner EJ, et al. The application of (Z)-3-aryl-3-haloenoic acids to the synthesis of (Z)-5-benzylidene-4-arylpyrrol-2(5H)-ones. Tetrahedron. 2010;66(47):9113-9122doi: 10.1016/j.tet.2010.09.080.
Gupton, J. T., Telang, N., Banner, E. J., Kluball, E. J., Hall, K. E., Finzel, K. L., Jia, X., Bates, S. R., Welden, R. S., Giglio, B. C., Eaton, J. E., Barelli, P. J., Firich, L. T., Stafford, J. A., Coppock, M. B., Worrall, E. F., Kanters, R. P., Keertikar, K., & Osterman, R. (2010). The application of (Z)-3-aryl-3-haloenoic acids to the synthesis of (Z)-5-benzylidene-4-arylpyrrol-2(5H)-ones. Tetrahedron, 66(47), 9113-9122. https://doi.org/10.1016/j.tet.2010.09.080
Gupton, John T, et al. "The application of (Z)-3-aryl-3-haloenoic acids to the synthesis of (Z)-5-benzylidene-4-arylpyrrol-2(5H)-ones." Tetrahedron vol. 66,47 (2010): 9113-9122. doi: https://doi.org/10.1016/j.tet.2010.09.080
Gupton JT, Telang N, Banner EJ, Kluball EJ, Hall KE, Finzel KL, Jia X, Bates SR, Welden RS, Giglio BC, Eaton JE, Barelli PJ, Firich LT, Stafford JA, Coppock MB, Worrall EF, Kanters RP, Keertikar K, Osterman R. The application of (Z)-3-aryl-3-haloenoic acids to the synthesis of (Z)-5-benzylidene-4-arylpyrrol-2(5H)-ones. Tetrahedron. 2010 Nov 20;66(47):9113-9122. doi: 10.1016/j.tet.2010.09.080. PMID: 21135918; PMCID: PMC2997076.
Copy Download .nbib Format: NLM
Surface-phonon dispersion investigation of the (1 x 1)-->(5 x 1) reconstruction of the Ir(100) surface.

Physical review. B, Condensed matter

Chen JG, Ibach H, Kisters G, Lehwald S, Preuss E.
PMID: 9997736
Phys Rev B Condens Matter. 1991 Feb 15;43(5):3920-3927. doi: 10.1103/physrevb.43.3920.

No abstract available.

Cite
Chen JG, Ibach H, Kisters G, et al. Surface-phonon dispersion investigation of the (1 x 1)-->(5 x 1) reconstruction of the Ir(100) surface. Phys Rev B Condens Matter. 1991;43(5):3920-3927doi: 10.1103/physrevb.43.3920.
Chen, J. G., Ibach, H., Kisters, G., Lehwald, S., & Preuss, E. (1991). Surface-phonon dispersion investigation of the (1 x 1)-->(5 x 1) reconstruction of the Ir(100) surface. Physical review. B, Condensed matter, 43(5), 3920-3927. https://doi.org/10.1103/physrevb.43.3920
Chen, et al. "Surface-phonon dispersion investigation of the (1 x 1)-->(5 x 1) reconstruction of the Ir(100) surface." Physical review. B, Condensed matter vol. 43,5 (1991): 3920-3927. doi: https://doi.org/10.1103/physrevb.43.3920
Chen JG, Ibach H, Kisters G, Lehwald S, Preuss E. Surface-phonon dispersion investigation of the (1 x 1)-->(5 x 1) reconstruction of the Ir(100) surface. Phys Rev B Condens Matter. 1991 Feb 15;43(5):3920-3927. doi: 10.1103/physrevb.43.3920. PMID: 9997736.
Copy Download .nbib Format: NLM
Effectiveness of various cleaning and disinfectant products on .

Antimicrobial resistance and infection control

Kenters N, Huijskens EGW, de Wit SCJ, Sanders IGJM, van Rosmalen J, Kuijper EJ, Voss A.
PMID: 28588767
Antimicrob Resist Infect Control. 2017 Jun 03;6:54. doi: 10.1186/s13756-017-0210-3. eCollection 2017.

No abstract available.

Cite
Kenters N, Huijskens EGW, de Wit SCJ, et al. Effectiveness of various cleaning and disinfectant products on . Antimicrob Resist Infect Control. 2017;6:54doi: 10.1186/s13756-017-0210-3.
Kenters, N., Huijskens, E. G. W., de Wit, S. C. J., Sanders, I. G. J. M., van Rosmalen, J., Kuijper, E. J., & Voss, A. (2017). Effectiveness of various cleaning and disinfectant products on . Antimicrobial resistance and infection control, 654. https://doi.org/10.1186/s13756-017-0210-3
Kenters, N, et al. "Effectiveness of various cleaning and disinfectant products on ." Antimicrobial resistance and infection control vol. 6 (2017): 54. doi: https://doi.org/10.1186/s13756-017-0210-3
Kenters N, Huijskens EGW, de Wit SCJ, Sanders IGJM, van Rosmalen J, Kuijper EJ, Voss A. Effectiveness of various cleaning and disinfectant products on . Antimicrob Resist Infect Control. 2017 Jun 03;6:54. doi: 10.1186/s13756-017-0210-3. eCollection 2017. PMID: 28588767; PMCID: PMC5457610.
Copy Download .nbib Format: NLM
Application of vinylogous carbamates and vinylogous aminonitriles to the regiospecific synthesis of uniquely functionalized pyrroles and quinolones.

Tetrahedron

Gupton JT, Crawford E, Mahoney M, Clark E, Curry W, Lane A, Shimozono A, Moore-Stoll V, Elofson K, Juekun W, Newton M, Yeudall S, Jaekle E, Kanters R, Sikorski JA.
PMID: 31289413
Tetrahedron. 2018 Dec 27;74(52):7408-7420. doi: 10.1016/j.tet.2018.10.078. Epub 2018 Nov 05.

Pyrroles and quinolones represent core structures, which are routinely found in both natural and synthetic bioactive substances. Consequently, the development of efficient and regiospecific methods for the preparation of such heterocycles with unique functionality is of some importance. We...

Cite
Gupton JT, Crawford E, Mahoney M, et al. Application of vinylogous carbamates and vinylogous aminonitriles to the regiospecific synthesis of uniquely functionalized pyrroles and quinolones. Tetrahedron. 2018;74(52):7408-7420doi: 10.1016/j.tet.2018.10.078.
Gupton, J. T., Crawford, E., Mahoney, M., Clark, E., Curry, W., Lane, A., Shimozono, A., Moore-Stoll, V., Elofson, K., Juekun, W., Newton, M., Yeudall, S., Jaekle, E., Kanters, R., & Sikorski, J. A. (2018). Application of vinylogous carbamates and vinylogous aminonitriles to the regiospecific synthesis of uniquely functionalized pyrroles and quinolones. Tetrahedron, 74(52), 7408-7420. https://doi.org/10.1016/j.tet.2018.10.078
Gupton, John T, et al. "Application of vinylogous carbamates and vinylogous aminonitriles to the regiospecific synthesis of uniquely functionalized pyrroles and quinolones." Tetrahedron vol. 74,52 (2018): 7408-7420. doi: https://doi.org/10.1016/j.tet.2018.10.078
Gupton JT, Crawford E, Mahoney M, Clark E, Curry W, Lane A, Shimozono A, Moore-Stoll V, Elofson K, Juekun W, Newton M, Yeudall S, Jaekle E, Kanters R, Sikorski JA. Application of vinylogous carbamates and vinylogous aminonitriles to the regiospecific synthesis of uniquely functionalized pyrroles and quinolones. Tetrahedron. 2018 Dec 27;74(52):7408-7420. doi: 10.1016/j.tet.2018.10.078. Epub 2018 Nov 05. PMID: 31289413; PMCID: PMC6615762.
Copy Download .nbib Format: NLM
Early glycaemic changes after initiation of oral antidiabetic medication and risk of major adverse cardiovascular events: results from a large primary care population of patients with type 2 diabetes.

European heart journal. Cardiovascular pharmacotherapy

Ghouse J, Blanche P, Skov MW, Lind B, Vaag A, Kanters JK, Svendsen JH, Køber L, Olesen MS, Gerds TA, Holst AG, Nielsen JB.
PMID: 32614428
Eur Heart J Cardiovasc Pharmacother. 2021 Nov 03;7(6):486-495. doi: 10.1093/ehjcvp/pvaa072.

AIMS: To determine the risk of major adverse cardiovascular events (MACE) and death, associated with an early large and rapid decline in glycated haemoglobin (HbA1C) following first time initiation of an oral antidiabetic drug (OAD).METHODS AND RESULTS: We included...

Cite
Ghouse J, Blanche P, Skov MW, et al. Early glycaemic changes after initiation of oral antidiabetic medication and risk of major adverse cardiovascular events: results from a large primary care population of patients with type 2 diabetes. Eur Heart J Cardiovasc Pharmacother. 2021;7(6):486-495doi: 10.1093/ehjcvp/pvaa072.
Ghouse, J., Blanche, P., Skov, M. W., Lind, B., Vaag, A., Kanters, J. K., Svendsen, J. H., Køber, L., Olesen, M. S., Gerds, T. A., Holst, A. G., & Nielsen, J. B. (2021). Early glycaemic changes after initiation of oral antidiabetic medication and risk of major adverse cardiovascular events: results from a large primary care population of patients with type 2 diabetes. European heart journal. Cardiovascular pharmacotherapy, 7(6), 486-495. https://doi.org/10.1093/ehjcvp/pvaa072
Ghouse, Jonas, et al. "Early glycaemic changes after initiation of oral antidiabetic medication and risk of major adverse cardiovascular events: results from a large primary care population of patients with type 2 diabetes." European heart journal. Cardiovascular pharmacotherapy vol. 7,6 (2021): 486-495. doi: https://doi.org/10.1093/ehjcvp/pvaa072
Ghouse J, Blanche P, Skov MW, Lind B, Vaag A, Kanters JK, Svendsen JH, Køber L, Olesen MS, Gerds TA, Holst AG, Nielsen JB. Early glycaemic changes after initiation of oral antidiabetic medication and risk of major adverse cardiovascular events: results from a large primary care population of patients with type 2 diabetes. Eur Heart J Cardiovasc Pharmacother. 2021 Nov 03;7(6):486-495. doi: 10.1093/ehjcvp/pvaa072. PMID: 32614428.
Copy Download .nbib Format: NLM
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials.

JAMA oncology

Chao J, Fuchs CS, Shitara K, Tabernero J, Muro K, Van Cutsem E, Bang YJ, De Vita F, Landers G, Yen CJ, Chau I, Elme A, Lee J, Özgüroglu M, Catenacci D, Yoon HH, Chen E, Adelberg D, Shih CS, Shah S, Bhagia P, Wainberg ZA.
PMID: 33792646
JAMA Oncol. 2021 Jun 01;7(6):895-902. doi: 10.1001/jamaoncol.2021.0275.

IMPORTANCE: Immunotherapy has been associated with improved outcomes among patients who have received previous treatment for microsatellite instability-high (MSI-H) tumors.OBJECTIVE: To evaluate the antitumor activity of pembrolizumab therapy vs chemotherapy among patients with MSI-H advanced gastric or gastroesophageal junction...

Cite
Chao J, Fuchs CS, Shitara K, et al. Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials. JAMA Oncol. 2021;7(6):895-902doi: 10.1001/jamaoncol.2021.0275.
Chao, J., Fuchs, C. S., Shitara, K., Tabernero, J., Muro, K., Van Cutsem, E., Bang, Y. J., De Vita, F., Landers, G., Yen, C. J., Chau, I., Elme, A., Lee, J., Özgüroglu, M., Catenacci, D., Yoon, H. H., Chen, E., Adelberg, D., Shih, C. S., Shah, S., Bhagia, P., & Wainberg, Z. A. (2021). Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials. JAMA oncology, 7(6), 895-902. https://doi.org/10.1001/jamaoncol.2021.0275
Chao, Joseph, et al. "Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials." JAMA oncology vol. 7,6 (2021): 895-902. doi: https://doi.org/10.1001/jamaoncol.2021.0275
Chao J, Fuchs CS, Shitara K, Tabernero J, Muro K, Van Cutsem E, Bang YJ, De Vita F, Landers G, Yen CJ, Chau I, Elme A, Lee J, Özgüroglu M, Catenacci D, Yoon HH, Chen E, Adelberg D, Shih CS, Shah S, Bhagia P, Wainberg ZA. Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials. JAMA Oncol. 2021 Jun 01;7(6):895-902. doi: 10.1001/jamaoncol.2021.0275. PMID: 33792646; PMCID: PMC8017478.
Copy Download .nbib Format: NLM
Intra- and interspecific variability among congeneric Pagellus otoliths.

Scientific reports

D'Iglio C, Albano M, Famulari S, Savoca S, Panarello G, Di Paola D, Perdichizzi A, Rinelli P, Lanteri G, Spanò N, Capillo G.
PMID: 34381131
Sci Rep. 2021 Aug 11;11(1):16315. doi: 10.1038/s41598-021-95814-w.

Otolith features are useful tools for studying taxonomy, ecology, paleontology, and fish biology since they represent a permanent record of life history. Nevertheless, the functional morphology of otoliths remains an open research question that is useful to completely understand...

Cite
D'Iglio C, Albano M, Famulari S, et al. Intra- and interspecific variability among congeneric Pagellus otoliths. Sci Rep. 2021;11(1):16315doi: 10.1038/s41598-021-95814-w.
D'Iglio, C., Albano, M., Famulari, S., Savoca, S., Panarello, G., Di Paola, D., Perdichizzi, A., Rinelli, P., Lanteri, G., Spanò, N., & Capillo, G. (2021). Intra- and interspecific variability among congeneric Pagellus otoliths. Scientific reports, 11(1), 16315. https://doi.org/10.1038/s41598-021-95814-w
D'Iglio, Claudio, et al. "Intra- and interspecific variability among congeneric Pagellus otoliths." Scientific reports vol. 11,1 (2021): 16315. doi: https://doi.org/10.1038/s41598-021-95814-w
D'Iglio C, Albano M, Famulari S, Savoca S, Panarello G, Di Paola D, Perdichizzi A, Rinelli P, Lanteri G, Spanò N, Capillo G. Intra- and interspecific variability among congeneric Pagellus otoliths. Sci Rep. 2021 Aug 11;11(1):16315. doi: 10.1038/s41598-021-95814-w. PMID: 34381131; PMCID: PMC8357811.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 178 entries